Earnings History Data for BioXcel Therapeutics, Inc. (BTAI) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

BioXcel Therapeutics, Inc.

BioXcel Therapeutics Inc. is a clinical stage biopharmaceutical company. It focuses on drug development which utilizes novel artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology. The company's product portfolio include BXCL501, a sublingual thin film formulation of dexmedetomidine designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer. BioXcel Therapeutics Inc. is based in the United States.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
09-05-2022 PM 7:00 AM ET
(May 9)
BTAI BioXcel Therapeutics, Inc. 383.61 -1.12 -1.21 -1.08 BioXcel Therapeutics GAAP EPS of -$1.12 beats by $0.01
[5/9/2022 7:10 AM]
11.31 -1.25 
(-9.91%)
12.50 -0.06 
(-0.47%)
11.28 - 39.00 792,291 460,000 28,663
10-03-2022 PM 7:00 AM ET
(Mar 10)
BTAI BioXcel Therapeutics, Inc. 498.89 -0.93 -1.18 -0.87 BioXcel Therapeutics GAAP EPS of -$0.93 beats by $0.21
[3/10/2022 7:08 AM]
16.71 -0.99 
(0.00%)
19.15 0.26 
(1.38%)
14.32 - 49.78 230,003 290,168 72,460
10-11-2021 PM 7:00 AM ET
(Nov 10)
BTAI BioXcel Therapeutics, Inc. 957.66 -0.96 -1.08 -1.07 BioXcel Therapeutics EPS beats by $0.11
[11/10/2021 7:20 AM]
34.20 0.33 
(0.97%)
33.87 0.0 
(0.00%)
23.07 - 67.74 231,068 200,000 250
10-08-2021 PM 7:00 AM ET
(Aug 10)
BTAI BioXcel Therapeutics, Inc. 728.02 -1.11 -1.03 -1.06 BioXcel Therapeutics EPS misses by $0.03
[8/10/2021 7:03 AM]
24.93 -0.06 
(-0.24%)
25.00 0.01 
(0.04%)
23.79 - 67.74 310,751 280,000 1,068
10-05-2021 PM 7:15 AM ET
(May 10)
BTAI BioXcel Therapeutics, Inc. 752.99 -1.08 -0.89 -0.79 BioXcel Therapeutics EPS misses by $0.14
[5/10/2021 7:12 AM]
30.44 -0.08 
(-0.26%)
30.52 0.0 
(0.00%)
29.50 - 71.50 404,937 310,000 4,960
11-03-2021 PM 7:00 AM ET
(Mar 11)
BTAI BioXcel Therapeutics, Inc. 1,080 -0.87 -0.86 -0.45 BioXcel Therapeutics EPS beats by $0.07
[3/11/2021 7:18 AM]
47.37 2.12 
(4.69%)
48.03 2.78 
(6.14%)
13.77 - 71.50 557,703 489,170 6,373
12-11-2020 PM 7:00 AM ET
(Nov 12)
BTAI BioXcel Therapeutics, Inc. 1,230 -1.07 -0.80 -0.57 BioXcel Therapeutics EPS misses by $0.28
[11/12/2020 7:05 AM]
55.21 -1.37 
(-2.42%)
56.77 0.19 
(0.34%)
4.20 - 71.50 346,202 409,554 3,552
14-08-2020 PM 7:00 AM ET
(Aug 14)
BTAI BioXcel Therapeutics, Inc. 1,050 -1.06 -0.74 -0.54 BioXcel Therapeutics EPS misses by $0.28
[8/14/2020 7:06 AM]
39.94 -4.77 
(-10.67%)
41.50 -3.21 
(-7.18%)
3.76 - 71.50 1,349,823 676,972 63,935
12-05-2020 PM 7:00 AM ET
(May 12)
BTAI BioXcel Therapeutics, Inc. 815.57 -0.79 -0.55 -0.46 BioXcel Therapeutics EPS misses by $0.21
[5/12/2020 7:02 AM]
40.68 -2.33 
(-5.42%)
40.68 0.0 
(0.00%)
3.76 - 44.41 454,838 468,661 959